A client with SIADH is being monitored for complications. Which finding should the nurse recognize as a sign of worsening condition?

The syndrome of inappropriate antidiuretic hormone (SIADH) features excessive, uninhibited arginine vasopressin secretion, inducing free water reabsorption via renal aquaporin-2 channels. This pathological volume expansion creates dilutional hyponatremia, forcing an osmotic fluid shift into cells. Intracellular swelling causes progressive cerebral edema, driving severe neurologic dysfunction and elevated intracranial pressure. A. Confusion and headache: Advancing dilutional hyponatremia drives an osmotic fluid influx into astrocytes, precipitating acute encephalopathy and cerebral edema. Serum sodium levels dropping below 120 mmol/L manifest as progressive altered mentation, cephalalgia, and potential seizure activity. This neuro-symptomatic progression signals critical clinical deterioration. B. Weight loss: Excessive antidiuretic activity expands the intravascular compartment, causing fluid retention and rapid, non-edematous weight gain. A reduction in body mass indicates effective therapeutic diuresis or successful fluid restriction rather than a worsening clinical state. This finding reflects a therapeutic response. C. Dry mucous membranes: Fluid retention and volume expansion suppress normal triggers for volume depletion, maintaining moist mucosal surfaces despite plasma hypo-osmolality. Dehydration signs like xerostomia or poor skin turgor indicate intravascular depletion, contradicting the fluid-overloaded state of SIADH. Their presence suggests alternative diagnostic etiologies. D. Increased urine output: Persistent vasopressin activity maximizes water reabsorption in the collecting ducts, producing highly concentrated, low-volume urine. An increase in urinary excretion demonstrates a resolution of the inappropriate hormone effect or successful pharmacological antagonism. It signifies physiological improvement rather than clinical decline.